The "Evolving Landscape for Diverse Clinical Trials: Legislation, Community & Stakeholders" topic was originally presented at the 2022 National Minority Quality Forum Annual Leadership Summit on Health Disparities and Health Braintrust. Listen now for a closer look at addressing existing disparities.
Panelists:
Mark Fleury, PhD, Policy Principal, American Cancer Society Cancer Action Network (ACS-CAN)
Lloryn Hubbard, Associate Director, Lead-Patient Diversity Clinical Research PPD, part of Thermo Fisher Scientific
Salvatore (Salvo) Alesci, MD, PhD, Chief Scientist & Strategy Officer, Beyond Celiac
Maha Radhakrishnan, MD Group, Senior Vice President & Chief Medical Officer, Biogen
Dora Hughes, MD, MPH, Chief Medical Officer, The CMS Innovation Center at the Centers for Medicare and Medicaid Services
Christina Edwards, MHA Clinical Trials Director National Minority Quality Forum (Moderator)
